egSEQ Comprehensive Solid Tumours
egSEQ Comprehensive Solid Tumours Panel is a hybridisation-based targeted sequencing panel covering 641 genes, 15 MSI sites and 38 fusion sites related to solid tumours and targeted therapies, allowing accurate, comprehensive and cost-effective analysis of all types of mutations, including SNVs, InDels, CNVs, and rearrangements. egSEQ Comprehensive Solid Tumours Panel provides a comprehensive approach to analysing actionable biomarkers relevant to oncological diagnosis, prognosis, and therapy.
2.13Mb target region coverage, including 641 genes and 38 gene fusion intron regions.
TMB and MSI for immunotherapy evaluation.
Market-leading capture efficiency of up to 75% and exceptional uniformity with 20X > 99%.
Available with UMI adapter for more precise analysis.
Targeted therapy and concomitant diagnosis.
Mutation analysis of tumour-related genes.
Suitable for patients with existing solid tumours and those with a family history.